FDA ap­proves Madri­gal’s NASH drug, mark­ing the first-ever treat­ment for the liv­er dis­ease

Madri­gal Phar­ma­ceu­ti­cals’ NASH drug won an ac­cel­er­at­ed ap­proval on Thurs­day, be­com­ing the first treat­ment for a liv­er dis­ease that for years has vexed sci­en­tists and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER